Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis

<div>Linear relationship between area under the curve (AUC) of voriconazole/clonazepam peak ratio and plasma concentration of voriconazole over a range of 0.125–10 <i>μ</i>g/ml (VRZ, voriconazole; IS, internal standard).</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

fig2

Figure 2

Figure 2: Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis 

Figure 2 | Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis 